Worldwide Hypertrophic and Keloid Scar Treatment Industry to 2027 – Advantages of Laser Treatment is Driving Growth – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Hypertrophic and Keloid Scar Treatment Market Forecast to 2027 – COVID-19 Impact and Global Analysis By Scar Type, Product Type, and End User, and Geography” report has been added to ResearchAndMarkets.com’s offering.
According to this report the global hypertrophic and keloid scar treatment market is expected to reach US$ 9,972.69 million by 2027 from US$ 4,498.99 million in 2019. It is estimated to grow at a CAGR of 10.6% from 2020 to 2027.
The report highlights trends prevailing in the market, and drivers and hindrances pertaining to the market growth. Factors such as advantages of laser treatment and increasing incidences of injuries are driving the market growth. However, the unavailability of universal treatment due to high costs, side effects, and scanty awareness hinder the market growth.
Based on scar type, the hypertrophic and keloid scar treatment market is segmented into hypertrophic and keloid. In 2019, the hypertrophic accounted for a larger share and is expected to grow at a faster pace during the forecast period, as hypertrophic scars are more common. Moreover, these scars do not grow outside the borders of the original wound and eventually grow smaller. Additionally, the treatment for hypertrophic scars typically requires non-invasive procedures such as gels, creams, and silicone sheets in the course of minor injuries and laser treatments.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hypertrophic and keloid scar treatment market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global hypertrophic and keloid scar treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
Market Dynamics
Drivers
- Advantages of Laser Treatment
- Increasing Cases of Injuries
Restraints
- Unavailability of Universal Treatment Due to High Costs, Side Effects, and Scanty Awareness
Opportunities
- Tapping Market in Emerging Regions
Future Trends
- Emerging Treatments Modalities
Companies Mentioned
- Alliance Pharma plc
- Molnlycke HEALTH CARE AB.
- Smith & Nephew
- Newmedical Technology Inc.
- Rejuvaskin
- Sonoma Pharmaceuticals, Inc.
- Suneva Medical
- HRA Pharma
- Lumenis
- Perrigo Company plc
For more information about this report visit https://www.researchandmarkets.com/r/3cx4zq
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900